Skip Navigation

Link to  the National Institutes of Health  
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Archives of the National Institute on Drug Abuse web site
Go to the Home page
   
Glutamate Cascade Research

The Glutamate Cascade: Common Pathways of Central Nervous System Disease States

Objective


To explore the evidence that the "glutamate cascade" appears to be associated with several seemingly diverse disease processes of the CNS. The related excitotoxic cascade has been demonstrated in some of these processes. The hope is to stimulate a cross-fertilization of ideas in basic brain mechanisms and preclinical and clinical medications development of direct or indirect glutamatergic antagonists in diverse medical disciplines which focus on these disorders.

Disorders in which a role for glutamate have been demonstrated include: addiction (tolerance, sensitization, dependence, and/or neurotoxicity that is associated with drugs of abuse including opiates, cocaine, amphetamine, alcohol); stroke; epilepsy; brain trauma; certain types of neuropathic pain; AIDS dementia; schizophrenia; depression; anxiety; and aging/Alzheimer's. A role of NMDA receptor complex and NO has also been implicated in LTP and in other models for learning and memory.


[Index] [Program List]


Archive Home | Accessibility | Privacy | FOIA (NIH) | Current NIDA Home Page
National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. . The U.S. government's official web portal